Interleukin 1β mediated calciotropic activity in serum of children with juvenile rheumatoid arthritis

Journal of Rheumatology

Volumn 25, Issue 1, 1998, Pages 161-165

  Schurman, Scott J ^a,c   Bergstrom, William H ^b   Root, Allen W ^a   Souid, Abdul K ^b   Hannan, William P ^b  

^a Florida College   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

Bone mineralization; Interleukin 1 ; Juvenile rheumatoid arthritis

Indexed keywords

CALCIUM; CREATININE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; NAPROXEN; PREDNISONE; THIAZIDE DIURETIC AGENT; TOLMETIN; VITAMIN D; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BONE METABOLISM; BONE MINERALIZATION; CALCIUM URINE LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; JUVENILE RHEUMATOID ARTHRITIS; MALE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; RAT; BLOOD; CASE REPORT; DRUG EFFECT; METABOLIC BONE DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BLOOD SEDIMENTATION; BONE DISEASES, METABOLIC; BONE RESORPTION; CALCIUM; CHILD; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; RECOMBINANT PROTEINS; SIALOGLYCOPROTEINS;

EID: 0031594521     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Joffe I, Epstein S. Osteoporosis associated with rheumatoid arthritis. Clin Rheumatol 1988;7:16-23.
2. Reed A, Haugen M, Pachman LM, Langman CB. Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. J Pediatr 1990;116:574-80.
3. Elsasser U, Wilkens B, Hesp R, Thurnham DI, Reeve J, Ansell BM. Bone rarefaction and crush fractures in juvenile chronic arthritis. Arch Dis Child 1982;57:377-80.
4. Hillman L, Cassidy JT, Johnson L, Lee D, Allen SH. Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J Pediatr 1994;124:910-6.
5. Stapleton FB, Hanissian AS, Miller LA. Hypercalciuria in children with juvenile rheumatoid arthritis: Association with hematuria. J Pediatr 1985;107:235-9.
6. Abrams SA, Lipnick RN, Vieira NE, Stuff JE, Yergey AL. Calcium absorption and metabolism in children with juvenile rheumatoid arthritis assessed using stable isotopes. J Rheumatol 1993;20:1196-200.
7. Cassidy JT, Levinson JE, Bass JC, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986;29:274-8.
8. Brewer EJ Jr, Giannini EH. Standard methodology for segment I, II, and III pediatric rheumatology collaborative study group studies. I. Design. J Rheumatol 1982;9:109-13.
9. Giannini EH, Brewer EJ Jr. Standard methodology for segment I, II, and III pediatric rheumatology collaborative study group studies. II. Analysis and presentation of data. J Rheumatol 1982;9:114-22.
10. Bergstrom W. Bone disc bioassay for calciotropic agents [abstract]. J Bone Miner Res 1992;7 Suppl 1:224.
11. Ragosta KG, Bergstrom WH, Briggs DG, Brandt B. Protamine and acute depletion of magnesium limit bone response to parathyroid hormone. Anesth Analg 1996;82:29-32.
12. Langman CB, Ford KK, Pachman LM, Glorieu F. Vitamin D metabolism in rats with adjuvant-induced arthritis. J Bone Miner Res 1990;5:905-13.
13. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
14. Roodman GD. Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 1993;53 Suppl 1:S94-S98.
15. Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD. Interleukin-1βis a potent inhibitor of bone formation in vitro. J Bone Miner Res 1987;2:559-65.
16. Goldie AS, Fearon KC, Ross JA, et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 1995;274:172-7.
17. Chikanza IC, Roux-Lombard P, Dayer JM, Panayi GS. Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications. Arthritis Rheum 1995;38:642-8.
18. Arend WP, Smith MF Jr, Janson RW, Joslin FG. IL-1 receptor antagonist and IL-1β production in human monocytes are regulated differently. J Immunol 1991;147:1530-6.
19. Frith SE, Hienich NA, Redfern CP, Goodship TH. Production of interleukin 1 receptor antagonist and interleukin 1 during haemodialysis with cellulose membranes. Int J Artif Organs 1994;17:478-87.
20. Madson KL, Moore TL, Lawrence JM III, Osborn TG. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994;21:2359-63.
21. Mangge H, Denzian H, Gallistl S, et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation and conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995;38:211-20.
22. Chikanza IC, Kingsley G, Panayi GS. Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis. J Rheumatol 1995;22:600-6.
23. Mundy GR. Identifying mechanisms for increasing bone mass. J NIH Res 1989;1:65-8.
24. Sabatier JP, Guaydier-Souquieres G, et al. Bone mineral acquisition during adolescence and early childhood: A study in 574 healthy females 10-24 years of age. Osteoporosis Int 1996;6:141-8.
25. Lewthwaite J, Blake S, Thompson RC, Hardingham TE, Henderson B. Antifibrinolytic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis. Ann Rheum Dis 1995;54:591-6.
26. Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano M. Dose-range and dose frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group. Arthritis Rheum 1996;39:1092-101.
27. Kimble RB, Vannice JL, Bloedow DC, et al. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 1994;93:1959-67.
28. Reusz G, Tulassay T, Szabo A, Miltenyi M. Effect of thiazide on urinary calcium excretion and haematuria in children with post-glomerular hematuria. Int J Pediatr Nephrol 1987;7:147-51.
29. Perrone HC, Bianco AC, Lewin S, et al. Hypercalciuric children: A 3.5 years prospective study of the bone mineral density [abstract]. J Bone Miner Res 1994;9:S347.
30. Wasnich RD, Benfante RJ, Yanko K, Heilbrun L, Vogel JM. Thiazide effect on the mineral content of bone. N Engl J Med 1983;309:344-7.